Walleye Capital’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Other funds holding DNA
EAM
ACG
JMFC
Walleye Capital's DNA Position: Q2 2026 in Review
Walleye Capital opened a new position in Ginkgo Bioworks (DNA) in Q2 2026: 19,066 shares worth $189K. The stake represents ﹤0.01% of the portfolio and ranks #3540 among its holdings. This is a return to the name: Walleye Capital previously reported a position in DNA as recently as Q4 2025.
Walleye Capital first reported a position in DNA in Q3 2024 and has held it in 4 quarters since. The position peaked at $2.61M in Q4 2024. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.
- Walleye Capital held 19,066 shares of Ginkgo Bioworks worth $189K as of Q2 2026.
- Ginkgo Bioworks was a new Walleye Capital position in Q2 2026.
- Ginkgo Bioworks made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3540 holding.
- Walleye Capital first reported a position in Ginkgo Bioworks in Q3 2024 and has held it in 4 quarters since.
- Walleye Capital's Ginkgo Bioworks position peaked at $2.61M in Q4 2024.
- 183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.
Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.